Health Technology Assessment

Supervision: prof. C.A. (Carin) Uyl-de Groot, PhD

iMTA is responsible for research programmes in the field of health economics and more specifically health technology assessment (HTA). The key is to determine the implications of the introduction, distribution and application of (new) medical technologies and to assess the resulting health gains. The main goal of HTA is to provide a bridge between research and policy. Health equity and accessibility to health care are other prominent research themes in which the Health Economics-iMTA research group is nationally and internationally leading.

Furthermore, iMTA group is involved in various research programmes, most of which are dealing with the area of health technology asessment. Another important research line is that of equily in the finance and delivery of health care.

Programmes

  • Cost-effectiveness analysis of health care programmes
  • Utility theory in economic evaluation of health care
  • Economics of health behavior and public health
  • Informal care: studying informal care, its impact on carers and care recipients, respite care, et cetera
  • Pharmaceutical policy
  • Economic studies in developing countries
  • Equity in the finance ande delivery of health care in developing countries
  • Income, health and work across the life cycle

The Institute for Medical Technology Assessment (iMTA) is linked to the Health Economics-iMTA research group and is an independent firm.